CAS NO: | 2130958-55-1 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
Cas No. | 2130958-55-1 |
别名 | 甲磺酸伏美替尼; Furmonertinib mesylate; AST2818 mesylate |
Canonical SMILES | C=CC(NC1=CC(NC2=NC=CC(C3=CN(C)C4=C3C=CC=C4)=N2)=C(OCC(F)(F)F)N=C1N(CCN(C)C)C)=O.CS(=O)(O)=O |
分子式 | C29H35F3N8O5S |
分子量 | 664.7 |
溶解度 | DMSO : 5 mg/mL (7.52 mM) |
储存条件 | Store at -20°C,unstable in solution, ready to use. |
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
产品描述 | AST2818 mesylate is an EGFR inhibitor. AST2818 mesylate is designed to inhibit EGFR active mutations as well as the T790M acquired resistant mutation[1]. [1]. Y.Shi, et al. P2.03-028 Third Generation EGFR Inhibitor AST2818 (Alflutinib) in NSCLC Patients with EGFR T790M Mutation: A phase1/2 Multi-Center Clinical Trial. J Thorac Oncol. 2017 Nov, 12(11): S2138. |